Cycurion Announces ~$800,000 in Annual Contract Spend from Pharma AI CoE, NACCHO and Commercial Wins

Cycurion (CYCU) shares rose 15% after announcing a $1M strategic partnership with a Fortune 500 company. The multi-year deal covers AI, security, and support. CYCU stock breached its 50-DMA for the first time since November 2025. The company expects growth and expansion opportunities.

Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

Cycurion (NASDAQ: CYCU) announced a 1-for-8 reverse stock split to meet NASDAQ requirements. The company reported a gross margin increase to 29.1% and a $54.6M 10-year HHS contract. It also authorized a $500K share repurchase program and aims for profitability by Q2 2027. CEO Kevin Kelly addressed market manipulation allegations.

Cycurion (CYCU) announced a 1-for-8 reverse stock split and a 10-year, $54.6M deal with HHS, expected to generate over $5M in annual recurring revenue. The company reported improved gross margins (29.1% in Q2 2026 vs. 6.1% in Q2 2025) and reduced net debt. Management targets profitability by Q2 2027 and authorized a $500K share repurchase program.

Cycurion (NASDAQ: CYCU) reported Q2 EPS of $(0.41), beating the $(0.56) consensus, and Q2 revenue of $3.757 million, above the $3.615 million estimate. However, sales fell 3.37% year over year to $3.888 million. The company also said its Nasdaq delisting hearing is set for Aug. 20, 2026.

Cycurion (CYCU) reported Q2 revenue of $3.76M, above consensus $3.62M, with gross margin rising to 29.1% (gross profit $1.09M). GAAP EPS loss was $(0.41), better than consensus $(0.56), and net loss improved to $(4.04)M. The company also won a $54.6M, 10-year contract expected to generate over $5M annually.